BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2015
View Archived Issues
Genomes-to-Natural Products platform identifies small-molecule bacterial metabolites
Read More
Southern Research Institute divulges HGF and MSP maturation inhibitors
Read More
University of Pennsylvania Treatment Research Center to begin phase II study of NS-2359
Read More
Eagle Pharmaceuticals reports phase II results for dantrolene in exertional heat stroke
Read More
VEGFR/FGFR kinase inhibitor sulfatinib enters phase III in neuroendocrine tumors
Read More
Ligand to acquire Open Monoclonal Technology
Read More
Cortex Pharmaceuticals changes name and provides pipeline update
Read More
Janssen and Bavarian Nordic to develop prime-boost vaccine for HPV
Read More
Oslo Universitetssykehus divulges SERCA2-PDE3A interaction inhibitors
Read More
Astellas Pharma and Kotobuki Pharmaceutical present IRAP and P-LAP inhibitors
Read More
CSL Behring seeks Japanese approval of long-acting recombinant FIX-albumin fusion protein
Read More
Ionis Pharmaceuticals is new name for Isis Pharmaceuticals
Read More
Saronic files IND for phase I/II trial of SBI-1997 for hepatocellular carcinoma
Read More
Brickell Biotech reports data from phase IIb BBI-4000 trial in hyperhidrosis
Read More
Alnylam files CTA for ALN-GO1 for the treatment of primary hyperoxaluria type 1
Read More
Veltassa now available in the U.S. for the treatment of hyperkalemia
Read More
CHMP recommends approval of Lilly's necitumumab and ramucirumab
Read More
Genmab confirms agreement to transfer remaining ofatumumab rights
Read More
Luminex receives FDA clearance for NxTAG respiratory pathogen panel
Read More
E-selectin antagonist GMI-1271 advances to study in leukemia patients
Read More
Acid ceramidase inhibitor ARN-14988 shows synergy with cytotoxic drugs against melanoma cells
Read More
Neuralstem reports data from phase Ib trial of NSI-189 in patients with MDD
Read More
Artefenomel clears Plasmodium infection in phase II trial
Read More
Avisa Pharma's breath test detects tuberculosis in pilot trial
Read More
FDA approves Uptravi for pulmonary arterial hypertension
Read More
OLIG2 pathway inhibitors show promise for the treatment of glioblastoma
Read More
Mallinckrodt to acquire The Medicines Company's hemostasis portfolio
Read More
Bristol-Myers Squibb discloses IDO inhibitors
Read More
EMA committee supports approval of Shield's Feraccru to treat iron deficiency anemia
Read More
EMA CHMP recommends approval of Sanofi Pasteur MSD's hexavalent vaccine Vaxelis
Read More